RAI CROP-PROTECTION PORTFOLIO

Held Registrations and Selected Registration Pipeline.

A focused portfolio reflecting RAI’s role as an Indonesian market-entry and registration-holder platform for crop-protection products.

RAI portfolio and Indonesia market-entry discussion

HELD PRODUCTS

Registrations Held by RAI

Current held registrations provide a practical foundation for selected crop-protection opportunities.

BESHIPO 500 SLDimehypo 500 g/LHeld
TUSOO 480 SCThiacloprid 480 g/LHeld
KUJII 600 ECButachlor 600 g/LHeld
BESCLOFIR 450 SCChlorfenapyr 450 g/LHeld

REGISTRATION PIPELINE

Selected Products Progressing Through the Pipeline

Pipeline products are evaluated as part of a broader commercial and market-entry case.

SEVASTOPOL 75 SPAcephate 75%Pipeline
ZOLAVEC 400 ECDifenoconazole 400 g/LPipeline
FENTINOVA 60 WPFentin acetate 60%Pipeline
EMAKOVIC 30 ECEmamectin benzoate 30 g/LPipeline
CLOVAK 250 SCPaclobutrazol 250 g/LPipeline

PORTFOLIO DEVELOPMENT

Selective Expansion, Backed by Evidence.

RAI screens crop-pest relevance, competitive position, formulation fit, field performance, price architecture and commercial potential before larger registration or market-development commitments.

RAI crop-protection portfolio field evaluation

HOW PORTFOLIO DECISIONS ARE MADE

A Registration Pipeline Should Follow the Commercial Case.

For new products, RAI considers the target crop–pest–province opportunity, competitive standards, local proof requirements, expected price corridor, supply control and the route to adoption before recommending deeper commitment. This helps international principals distinguish products that deserve immediate registration investment from those that should first undergo field validation or broader Indonesia market-opportunity assessment. Registration processing itself remains coordinated with qualified specialist regulatory partners.

FOR INTERNATIONAL PRINCIPALS

Have a Product or Portfolio for Indonesia?

Share the active ingredient, formulation, target crop and intended positioning. We can begin with a focused feasibility review and identify whether field validation or a broader market-entry discussion is warranted.